These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20544957)

  • 1. FoldGPCR: structure prediction protocol for the transmembrane domain of G protein-coupled receptors from class A.
    Michino M; Chen J; Stevens RC; Brooks CL
    Proteins; 2010 Aug; 78(10):2189-201. PubMed ID: 20544957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving homology modeling of G-protein coupled receptors through multiple-template derived conserved inter-residue interactions.
    Chaudhari R; Heim AJ; Li Z
    J Comput Aided Mol Des; 2015 May; 29(5):413-20. PubMed ID: 25503850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying conformational changes of the beta(2) adrenoceptor that enable accurate prediction of ligand/receptor interactions and screening for GPCR modulators.
    Reynolds KA; Katritch V; Abagyan R
    J Comput Aided Mol Des; 2009 May; 23(5):273-88. PubMed ID: 19148767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the structure of opioid receptors with homology modeling based on single and multiple templates and subsequent docking: a comparative study.
    Bera I; Laskar A; Ghoshal N
    J Mol Model; 2011 May; 17(5):1207-21. PubMed ID: 20661609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-ray structure breakthroughs in the GPCR transmembrane region.
    Topiol S; Sabio M
    Biochem Pharmacol; 2009 Jul; 78(1):11-20. PubMed ID: 19447219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes.
    Katritch V; Reynolds KA; Cherezov V; Hanson MA; Roth CB; Yeager M; Abagyan R
    J Mol Recognit; 2009; 22(4):307-18. PubMed ID: 19353579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of structural distortions in the transmembrane helices of GPCRs.
    Deupi X
    Methods Mol Biol; 2012; 914():219-35. PubMed ID: 22976031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
    Huber T; Menon S; Sakmar TP
    Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful prediction of the intra- and extracellular loops of four G-protein-coupled receptors.
    Goldfeld DA; Zhu K; Beuming T; Friesner RA
    Proc Natl Acad Sci U S A; 2011 May; 108(20):8275-80. PubMed ID: 21536915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
    Yuzlenko O; Kieć-Kononowicz K
    J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
    Goetz A; Lanig H; Gmeiner P; Clark T
    J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand entry and exit pathways in the beta2-adrenergic receptor.
    Wang T; Duan Y
    J Mol Biol; 2009 Oct; 392(4):1102-15. PubMed ID: 19665031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the applicability of GPCR homology models to computer-aided drug discovery: a comparison between in silico and crystal structures of the beta2-adrenergic receptor.
    Costanzi S
    J Med Chem; 2008 May; 51(10):2907-14. PubMed ID: 18442228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do crystal structures obviate the need for theoretical models of GPCRs for structure-based virtual screening?
    Tang H; Wang XS; Hsieh JH; Tropsha A
    Proteins; 2012 Jun; 80(6):1503-21. PubMed ID: 22275072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.
    Cherezov V; Rosenbaum DM; Hanson MA; Rasmussen SG; Thian FS; Kobilka TS; Choi HJ; Kuhn P; Weis WI; Kobilka BK; Stevens RC
    Science; 2007 Nov; 318(5854):1258-65. PubMed ID: 17962520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of a beta1-adrenergic G-protein-coupled receptor.
    Warne T; Serrano-Vega MJ; Baker JG; Moukhametzianov R; Edwards PC; Henderson R; Leslie AG; Tate CG; Schertler GF
    Nature; 2008 Jul; 454(7203):486-91. PubMed ID: 18594507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G protein-coupled receptors--recent advances.
    Latek D; Modzelewska A; Trzaskowski B; Palczewski K; Filipek S
    Acta Biochim Pol; 2012; 59(4):515-29. PubMed ID: 23251911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling and active site refinement for G protein-coupled receptors: application to the beta-2 adrenergic receptor.
    Krystek SR; Kimura SR; Tebben AJ
    J Comput Aided Mol Des; 2006; 20(7-8):463-70. PubMed ID: 17054017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New vistas in GPCR 3D structure prediction.
    Rayan A
    J Mol Model; 2010 Feb; 16(2):183-91. PubMed ID: 19551412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.